A discovery made five years ago by scientists at MDI Biological Laboratory (MDIBL) is causing quite a lot of excitement. It’s a molecule with the scintillating name of MSI-1436 that has been shown to stimulate the repair and regeneration of heart muscle in mice after a heart attack. Following that breakthrough, MDIBL President Kevin Strange and his research colleague Voot Yin created a company called Novo Biosciences to explore the molecule’s potential to have the same effect in other mammals and ultimately in humans. “People have been looking for drugs to do what ours does for 45 years,” Strange said. “We don’t know if it will work in humans, but if it does it will change the world. It will change the way we treat a heart attack. Read More
MDI Bio Lab spawning business ventures
Related Posts
Portland startup Marin Skincare launches lobster-based lip treatment
Portland startup Marin Skincare, known for its “lobster lotion,” is expanding that product line to include lip treatments. Founded out of the University...
UMaine scientists use eDNA to enhance river herring recovery research in Penobscot River
University of Maine researchers are seeking to gain more insight into river herring recovery in the Penobscot River using a novel...
FocusMaine co-founder named group’s next president
Nearly a decade after Andrea Cianchette Maker joined forces with Michael Dubyak to launch FocusMaine, Maker will lead the organization as...